Celmatix Launches Personalized Reproductive Medicine Consortium | GenomeWeb

NEW YORK (GenomeWeb) – Celmatix, a personalized medicine company focused on fertility and women's health, has launched the Personalized Reproductive Medicine Initiative, an effort to investigate how unique genetic signatures and personalized metrics affect overall fertility.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.